Tiribuzi et al. isolated CD14+ monocytes from 22 patients with AD presenting moderate cognitive impairment and found that trans-crocetin (5 μmol) promoted the degradation of Aβ42 in AD monocytes by upregulating lysosomal protease cathepsin B (Tiribuzi et al., 2016). Here, CD14 is linked to Alzheimer disease.